|
Volumn 31, Issue 5, 2008, Pages 487-490
|
Selection of HLA-A2 restricted CML28 peptide by artificial antigen-presenting cells
|
Author keywords
Artificial antigen presenting cells; CML28; CTLs
|
Indexed keywords
ANTILEUKEMIC AGENT;
CD28 ANTIGEN;
CHRONIC MYELOGENOUS LEUKEMIA 28;
HLA A2 ANTIGEN;
UNCLASSIFIED DRUG;
EPITOPE;
EXORIBONUCLEASE;
EXOSC5 PROTEIN, HUMAN;
MEMBRANE ANTIGEN;
TUMOR ANTIGEN;
AMINO ACID SEQUENCE;
ANTIGEN PRESENTING CELL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CD8+ T LYMPHOCYTE;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
CYTOTOXICITY;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
LYMPHOCYTE PROLIFERATION;
PRIORITY JOURNAL;
CELL CULTURE;
CELL PROLIFERATION;
CHEMISTRY;
COCULTURE;
CYTOLOGY;
IMMUNOLOGY;
AMINO ACID SEQUENCE;
ANTIGEN-PRESENTING CELLS;
ANTIGENS, NEOPLASM;
ANTIGENS, SURFACE;
CD8-POSITIVE T-LYMPHOCYTES;
CELL PROLIFERATION;
CELLS, CULTURED;
COCULTURE TECHNIQUES;
EPITOPES;
EXORIBONUCLEASES;
HLA-A2 ANTIGEN;
HUMANS;
|
EID: 55249108959
PISSN: 15249557
EISSN: None
Source Type: Journal
DOI: 10.1097/CJI.0b013e318176facc Document Type: Article |
Times cited : (4)
|
References (7)
|